A prospective study to investigate safety and tolerability of shorter infusion of Fabrazyme

Trial Identifier: LPS17726
Sponsor: Sanofi
Start Date: November 2023
Primary Completion Date: October 2025
Study Completion Date: October 2025
Condition: Fabry's Disease

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
UNITED STATES, California Santa Monica, California, UNITED STATES, 90404
UNITED STATES, Georgia Atlanta, Georgia, UNITED STATES, 30322-1007
UNITED STATES, Michigan Grand Rapids, Michigan, UNITED STATES, 49525
UNITED STATES, New York New York, UNITED STATES, 10021
UNITED STATES, Virginia Fairfax, Virginia, UNITED STATES, 22030